Found 6 matching trials
A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations PHASE1 The goal of this clinical trial is to evaluate the safety and preliminary e...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors PHASE1 The goal of this clinical trial is to evaluate the safety and preliminary e...
Show More Location
the first affiliated hospital of Jilin university
Learn More & Join Trial
A Study of WX390 in Patients With Advanced Solid Tumors PHASE2 The goal of this clinical trial is to evaluate the efficacy and safety of W...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations PHASE2 The goal of this clinical trial is to evaluate the safety and preliminary e...
Show More Location
The Obstetrics & Gynecology Hospital of Fudan University (Shanghai Red House Ob & Gyn Hospital)
Learn More & Join Trial
A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma PHASE1 WXFL10030390 (WX390) is a novel oral small molecular that inhibits phosphoi...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment PHASE3 This is a Randomized, Open-Label, Controlled, Multicenter Phase III Clinica...
Show More Location
Multiple Locations
Learn More & Join Trial